ArticleMedicine2025
Composite lipid-inflammatory indices and mortality risk in NHANES 2007-2016.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to investigate the associations of atherogenic index of plasma (AIP), systemic immune-inflammatory index (SII), monocyte-to-high-density lipoprotein cholesterol ratio (MHR), and neutrophil-to-high-density lipoprotein cholesterol ratio (NHR) with cardiovascular disease (CVD) mortality and all-cause mortality. Utilizing data from the National Health and Nutrition Examination Survey 2007-2016, Cox proportional hazards models were employed to evaluate the relationships between these biomarkers and mortality outcomes. Analysis of 11,188 participants based on Framingham Risk Scores revealed that higher AIP, SII, NHR, and MHR levels are significant risk factors for cardiovascular and all-cause mortality. These associations remained robust after adjusting for covariates including age, sex, race, smoking, and alcohol consumption. Similar trends were observed for all-cause mortality. AIP, SII, MHR, and NHR are associated with an increased risk of CVD and all-cause mortality, suggesting their potential utility as novel biomarkers for risk stratification in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.